Write in a clean editor, then format for Drug Development Research in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Drug Development Research is a peer-reviewed journal published by Wiley, covering Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Drug Development Research 12 (3): 45–58.
Formats any DOI in Drug Development Research style. No sign-up. |
| Publishes research in | Neuroscience and Neuropharmacology Research Receptor Mechanisms and Signaling Neurotransmitter Receptor Influence on Behavior Adenosine and Purinergic Signaling Cholinesterase and Neurodegenerative Diseases |
| ISSN | 0272-4391 |
| Citation impact (2-yr) | 3.31 |
| h-index | 96 |
| i10-index | 1,921 |
| Total citations | 73,759 |
| Article processing charge | $3,610 |
| Top institutions publishing here | Janssen (Belgium) |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract During 1985–1990 the U.S. National Cancer Institute (NCI) phased out its murine leukemia P388 anticancer drug screening program and developed as the replacement a new in vitro primary screen based upon a diverse panel of human tumor cell lines. For each substance tested, the screen generates a remarkably reproducible and characteristic profile of differential…
Abstract Targeting specific sites in vivo for the delivery of therapeutic compounds presents a major obstacle to the treatment of many diseases. One targeted delivery technique that has gained prominence in recent years is the use of magnetic nanoparticles. In these systems, therapeutic compounds are attached to biocompatible magnetic nanoparticles and magnetic fields generated outside…
At the time of writing this commentary (February 2020), the coronavirus COVID-19 epidemic has already resulted in more fatalities compared with the SARS and MERS coronavirus epidemics combined. Therapeutics that may assist to contain its rapid spread and reduce its high mortality rates are urgently needed. Developing vaccines against the SARS-CoV-2 virus may take many…
Abstract MK‐801 prevented tonic extensor seizures in the rat induced by bicuclline with the ED 50 being 23 μg/kg p.o. Clonazepam, phenobarbital, diazepam, phenytoin, γ‐acetylenic GABA, sodium valproate, and trimethadione were all less potent. In mice, MK‐801 was likewise the most potent (ED 50 = 0.35 mg/kg p.o.) compound in protecting against tonic seizures induced…
Abstract Nanotechnology applied to biological problems represents an emerging field with the potential to offer extremely sensitive diagnostics and targeted cancer therapies. However, to achieve these goals, nanoparticle delivery systems must outwit the many barriers that are intrinsic to the body's defenses, as well as those that develop during the growth and progression of tumors.…
